Inventor · disambiguated record
Wayne C. Drevets
Also filed as: DREVETS WAYNE · DREVETS WAYNE C · DREVETS WAYNE CURTIS
19 granted patents·18 pending applications·71 citations·filing 2005–2025
93Inventor score
Files withJANSSEN PHARMACEUTICALS INC21JANSSEN PHARMACEUTICA NV12FUREY MAURA L1JANSSEN BIOTECH INC1LAUREATE INSTITUTE FOR BRAIN RES1
Top patents by PatentIndex Score
37 records- 0196US11266627B1Compositions and methods for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2021·Granted Mar 8, 2022·12 cites·30 claims
- 0295US11998525B2Compositions and methods for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2023·Granted Jun 4, 2024·5 cites·29 claims
- 0394US12150929B2Compositions and methods for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2024·Granted Nov 26, 2024·2 cites·19 claims
- 0493US12161622B2Compositions and methods for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2022·Granted Dec 10, 2024·2 cites·29 claims
- 0592US11241432B2Methods of treating depression using orexin-2 receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Feb 8, 2022·3 cites·30 claims
- 0692US11173134B2Methods for the treatment of depressionJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Nov 16, 2021·3 cites·30 claims
- 0791US10869844B2Methods for the treatment of depressionJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Dec 22, 2020·11 cites·30 claims
- 0890US10098854B2Method for the treatment of depressionJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Oct 16, 2018·17 cites·6 claims
- 0989US10828302B2Methods of treating depression using orexin-2 receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Nov 10, 2020·8 cites·59 claims
- 1088US12419859B2Compositions and methods for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2024·Granted Sep 23, 2025·0 cites·7 claims
- 1186US11311500B2Methods for the treatment of depressionJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Apr 26, 2022·1 cites·22 claims
- 1284US11707440B2Esketamine for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2018·Granted Jul 25, 2023·4 cites·17 claims
- 1380US12171743B2Forms of aticaprantJANSSEN PHARMACEUTICALS INC·Filed 2024·Granted Dec 24, 2024·0 cites·30 claims
- 1477US12201610B2Compositions comprising aticaprantJANSSEN PHARMACEUTICALS INC·Filed 2024·Granted Jan 21, 2025·0 cites·19 claims
- 1577US2025326714A1Pure forms of crystalline aticaprantJANSSEN PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1676US12201634B2Methods of treating depression using orexin-2 receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Jan 21, 2025·0 cites·26 claims
- 1776US2023089113A1Methods For The Treatment Of DepressionJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 1876US2025325515A1Forms Of AticaprantJANSSEN PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1975US11998524B2Forms of aticaprantJANSSEN PHARMACEUTICALS INC·Filed 2023·Granted Jun 4, 2024·0 cites·44 claims
- 2074US2025332121A1Esketamine For The Treatment Of DepressionJANSSEN PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2171US2025255835A1Methods For The Treatment Of DepressionJANSSEN PHARMACEUTICA NV·Filed 2025·Application pending·0 cites
- 2270US2024000728A1Esketamine for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2368US2025221992A1Methods Of Treating Depression Using Orexin-2 Receptor AntagonistsJANSSEN PHARMACEUTICA NV·Filed 2025·Application pending·0 cites
- 2467US2025177350A1Compositions and methods for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2567US2023277500A1Compositions comprising aticaprantJANSSEN PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2666US9707220B2Scopolamine for the treatment of depression and anxietyUS HEALTH·Filed 2014·Granted Jul 18, 2017·1 cites·20 claims
- 2765US8859585B2Scopolamine for the treatment of depression and anxietyFUREY MAURA L·Filed 2005·Granted Oct 14, 2014·2 cites·18 claims
- 2862US2025090482A1Compositions and methods for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2962US2025064779A1Compositions and methods for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3061US2023348377A1Pure forms of crystalline aticaprantJANSSEN PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3161US2025221960A1Compositions and methods for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3260US2024122928A1Methods For Treating Agitation In Subjects With Mild Cognitive Impairment Or Major Neurocognition DisorderJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 3359US2024238245A1Compositions and methods for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3459US2025228819A1Compositions comprising aticaprantJANSSEN PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 3546US2019345245A1Methods of Treating Crohn's Disease with Anti-IL23 Specific AntibodyJANSSEN BIOTECH INC·Filed 2019·Application pending·0 cites
- 3641US2016338977A1Methods and kits for treating depressionJANSSEN PHARMACEUTICA NV·Filed 2016·Application pending·0 cites
- 3734US10213444B2Composition and method for treating bipolar disorderLAUREATE INSTITUTE FOR BRAIN RES·Filed 2015·Granted Feb 26, 2019·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Wayne C. Drevets files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →